95% CI, 0.96-3.85, respectively)
Retatrutide does not have one universal starting dose
The most commonly known incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), formerly called Gastric inhibitory peptide ( In view of this, a widespread search of SCOPUS, PubMed, and CENTRAL was performed using the following string (obesity or insulin resistance) AND (tirzepatide or Dual GIP and GLP-1 Receptor Agonist)
B stands for Border
doi: 10.1016/j.jphotobiol.2014.09.011
The 2025 Frontiers in Aging clinical review (Frontiers in Aging 2025) summarises the documented short-term adverse effects in adult populations: peripheral oedema and fluid retention are common at initiation, carpal tunnel syndrome occurs in a meaningful proportion of users, hyperglycaemia and insulin resistance can emerge because GH is physiologically counter-regulatory to insulin, and gynaecomastia has been reported, particularly at higher doses